Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”

Bibliographic Details
Main Authors:	Seul Ki Han, Soon Koo Baik, Moon Young Kim
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2023-07-01
Series:	Clinical and Molecular Hepatology
Subjects:	non-alcoholic fatty liver disease steatohepatitis fibrosis
Online Access:	http://e-cmh.org/upload/pdf/cmh-2023-0155.pdf

Similar Items

Non-alcoholic fatty liver disease: Definition and subtypes
by: Seul Ki Han, et al.
Published: (2023-02-01)

Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
by: Seogsong Jeong, et al.
Published: (2023-07-01)

Platelets in Non-alcoholic Fatty Liver Disease
by: Andrea Dalbeni, et al.
Published: (2022-02-01)

Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
by: Sina Ghandian, et al.
Published: (2022-03-01)

MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives
by: Mette Yde Hochreuter, et al.
Published: (2022-11-01)

Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
by: Sandra Steensels, et al.
Published: (2020-07-01)

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
by: Yamei Duan, et al.
Published: (2022-05-01)

Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
by: Stephen D. H. Malnick, et al.
Published: (2022-12-01)

Assessment of Ultra-Early-Stage Liver Fibrosis in Human Non-Alcoholic Fatty Liver Disease by Second-Harmonic Generation Microscopy
by: Takeo Minamikawa, et al.
Published: (2022-03-01)

Treatment Options in Non-alcoholic Fatty Liver Disease
by: Won Kim
Published: (2017-06-01)

The diagnostic conundrum in non-alcoholic fatty liver disease
by: Valerio Rosato, et al.
Published: (2020-10-01)

Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease
by: Anne-Marieke Van Dijk, et al.
Published: (2021-06-01)

ALS-L1023 from <i>Melissa officinalis</i> Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model
by: Eun Jeoung Lee, et al.
Published: (2022-12-01)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Daryl Ramai, et al.
Published: (2021-12-01)

Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up
by: Suguru Ikeda, et al.
Published: (2021-12-01)

Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
by: Aidan J. McGlinchey, et al.
Published: (2022-05-01)

USING NON-INVASIVE BIOMARKERS AND PLACE OF CYTOKERATIN 18 IN DIAGNOSIS PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: N. V. Dynnyk
Published: (2016-04-01)

Improvement of Diagnostic Algorithm in Patients With Alcoholic Fatty Liver Disease by Using Non-invasive Methods of Verification of Liver Steatosis and Fibrosis
by: Svintsitskyy A., et al.
Published: (2016-07-01)

O-GlycNacylation Remission Retards the Progression of Non-Alcoholic Fatty Liver Disease
by: Yicheng Zhou, et al.
Published: (2022-11-01)

Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children
by: Yiyoung Kwon, et al.
Published: (2022-04-01)

Pediatric non-alcoholic fatty liver disease
by: Delvin Edgard, et al.
Published: (2015-01-01)

A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8+ T Cells in a Nonalcoholic Steatohepatitis Mouse Model
by: Natalia Muñoz-Durango, et al.
Published: (2020-12-01)

Inflammation is not the cause of an elevated serum ferritin in non-alcoholic fatty liver disease
by: Melanie D. Beaton, et al.
Published: (2014-05-01)

Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
by: Aamir Bashir, et al.
Published: (2022-06-01)

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
by: Kuei-Chuan Lee, et al.
Published: (2023-01-01)

Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease
by: Alexey A. Goncharov, et al.
Published: (2023-10-01)

Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease
by: Ilkay S. Idilman, et al.
Published: (2021-06-01)

Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease
by: Ji Ye Hyun, et al.
Published: (2022-08-01)

Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches
by: Angelo Armandi, et al.
Published: (2021-06-01)

Association of C-reactive protein with histological, elastographic, and sonographic indices of non-alcoholic fatty liver disease in individuals with severe obesity
by: Tannaz Jamialahmadi, et al.
Published: (2023-04-01)

Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients
by: Rubén Díez-Rodríguez, et al.
Published: (2014-12-01)

Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients
by: Yan Huang, et al.
Published: (2022-01-01)

Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review
by: Yuichiro Eguchi, et al.
Published: (2020-10-01)

Non Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
by: Alabagi Abdulla, et al.
Published: (2016-04-01)

Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
by: Eileen L. Yoon, et al.
Published: (2023-10-01)

RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: Lourianne Nascimento CAVALCANTE, et al.
Published: (2022-11-01)

Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice
by: Nana Makiuchi, et al.
Published: (2023-09-01)

Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease
by: Lauren A. Newman, et al.
Published: (2020-06-01)

Relationship between serum 25-hydroxyvitamine D and non-alcoholic fatty liver disease
by: S.M. Tkach, et al.
Published: (2023-05-01)

Effect of mediterranean diet on non-alcoholic fatty liver disease (NAFLD)
by: Patrycja Walczak, et al.
Published: (2023-01-01)